Regions Financial Corp Amgen Inc Transaction History

Regions Financial Corp

$13.8 Billion
Q3 2024

A detailed history of Regions Financial Corp transactions in Amgen Inc stock. As of the latest transaction made, Regions Financial Corp holds 14,787 shares of AMGN stock, worth $4.29 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

14,787

Previous 14,742 0.31%

Holding current value

$4.29 Million

Previous $4.61 Million 3.43%

% of portfolio

0.03%

Previous 0.04%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$309.38 - $337.38 $13,922 - $15,182	45 Added 0.31%	14,787 $4.76 Million
Q2 2024 Jul 31, 2024	SELL	$262.75 - $319.31 $468,746 - $569,649	-1,784 Reduced 10.8%	14,742 $4.61 Million
Q1 2024 Apr 23, 2024	SELL	$268.87 - $324.56 $93,297 - $112,622	-347 Reduced 2.06%	16,526 $4.7 Million
Q4 2023 Feb 06, 2024	SELL	$255.7 - $288.46 $6,136 - $6,923	-24 Reduced 0.14%	16,873 $4.86 Million
Q3 2023 Nov 01, 2023	SELL	$218.65 - $271.46 $103,858 - $128,943	-475 Reduced 2.73%	16,897 $4.54 Million
Q2 2023 Aug 09, 2023	SELL	$214.27 - $253.37 $1.08 Million - $1.28 Million	-5,046 Reduced 22.51%	17,372 $3.86 Million
Q1 2023 May 12, 2023	BUY	$225.79 - $275.2 $39,513 - $48,160	175 Added 0.79%	22,418 $5.42 Million
Q4 2022 Feb 03, 2023	SELL	$229.03 - $291.01 $221,013 - $280,824	-965 Reduced 4.16%	22,243 $5.84 Million
Q3 2022 Nov 03, 2022	SELL	$224.46 - $253.15 $304,143 - $343,018	-1,355 Reduced 5.52%	23,208 $5.23 Million
Q2 2022 Jul 25, 2022	SELL	$230.71 - $256.74 $348,372 - $387,677	-1,510 Reduced 5.79%	24,563 $5.98 Million
Q1 2022 Apr 25, 2022	BUY	$219.27 - $242.57 $8,770 - $9,702	40 Added 0.15%	26,073 $6.31 Million
Q4 2021 Jan 31, 2022	SELL	$198.88 - $227.6 $363,950 - $416,508	-1,830 Reduced 6.57%	26,033 $5.86 Million
Q3 2021 Nov 04, 2021	SELL	$212.27 - $248.7 $553,600 - $648,609	-2,608 Reduced 8.56%	27,863 $5.93 Million
Q2 2021 Jul 27, 2021	BUY	$233.58 - $259.14 $148,790 - $165,072	637 Added 2.14%	30,471 $7.43 Million
Q1 2021 Jun 02, 2021	SELL	$221.91 - $258.6 $141,134 - $164,469	-636 Reduced 2.09%	29,834 $7.42 Million
Q4 2020 Feb 05, 2021	BUY	$216.38 - $257.67 $399,437 - $475,658	1,846 Added 6.45%	30,470 $7.01 Million
Q3 2020 Oct 15, 2020	SELL	$234.65 - $260.95 $42,940 - $47,753	-183 Reduced 0.64%	28,624 $7.28 Million
Q2 2020 Jul 27, 2020	BUY	$197.81 - $242.74 $144,994 - $177,928	733 Added 2.61%	28,807 $6.8 Million
Q1 2020 Apr 29, 2020	SELL	$182.24 - $241.7 $155,815 - $206,653	-855 Reduced 2.96%	28,074 $5.69 Million
Q4 2019 Feb 03, 2020	SELL	$189.21 - $243.2 $63,952 - $82,201	-338 Reduced 1.15%	28,929 $6.97 Million
Q3 2019 Oct 24, 2019	BUY	$174.11 - $208.62 $64,420 - $77,189	370 Added 1.28%	29,267 $5.66 Million
Q2 2019 Jul 19, 2019	SELL	$166.7 - $195.41 $178,869 - $209,674	-1,073 Reduced 3.58%	28,897 $5.33 Million
Q1 2019 Apr 19, 2019	SELL	$180.87 - $203.88 $227,172 - $256,073	-1,256 Reduced 4.02%	29,970 $5.69 Million
Q4 2018 Jan 28, 2019	SELL	$178.4 - $208.25 $1,427 - $1,666	-8 Reduced 0.03%	31,226 $6.08 Million
Q3 2018 Oct 22, 2018	SELL	$185.29 - $208.89 $2.26 Million - $2.55 Million	-12,214 Reduced 28.11%	31,234 $6.47 Million
Q2 2018 Jul 26, 2018	SELL	$166.05 - $186.51 $1.96 Million - $2.21 Million	-11,829 Reduced 21.4%	43,448 $8.02 Million
Q1 2018 Apr 18, 2018	BUY	$169.43 - $198.0 $89,459 - $104,544	528 Added 0.96%	55,277 $9.42 Million
Q4 2017 Jan 18, 2018	BUY	$168.79 - $188.59 $282,216 - $315,322	1,672 Added 3.15%	54,749 $9.52 Million
Q3 2017 Oct 23, 2017	BUY	$167.29 - $191.0 $8.88 Million - $10.1 Million	53,077	53,077 $9.9 Million

Others Institutions Holding AMGN

# of Institutions

3,122

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $155B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Regions Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Regions Financial Corp with notifications on news.

Account

Regions Financial Corp Amgen Inc Transaction History